Bonesupport ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  14.9% 14.4% 7.3% 15.7% 12.1%  
Credit score (0-100)  15 15 32 11 19  
Credit rating  BB BB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  3,374 0 0 0 0  
Gross profit  1,502 1,273 1,694 1,535 2,269  
EBITDA  160 106 605 -61.3 -23.6  
EBIT  160 106 605 -61.3 -23.6  
Pre-tax profit (PTP)  135.0 107.3 640.7 21.7 23.4  
Net earnings  103.3 80.8 496.8 14.8 18.0  
Pre-tax profit without non-rec. items  135 107 641 21.7 23.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  153 234 731 746 764  
Interest-bearing liabilities  752 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,200 808 1,234 1,316 1,464  

Net Debt  720 -30.2 -102 -81.4 -40.3  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  3,374 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  1,502 1,273 1,694 1,535 2,269  
Gross profit growth  0.0% -15.2% 33.1% -9.4% 47.9%  
Employees  1 1 1 1 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,200 808 1,234 1,316 1,464  
Balance sheet change%  0.0% -32.7% 52.7% 6.7% 11.2%  
Added value  159.5 106.4 605.2 -61.3 -23.6  
Added value %  4.7% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 -2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  4.7% 0.0% 0.0% 0.0% 0.0%  
EBIT %  4.7% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  10.6% 8.4% 35.7% -4.0% -1.0%  
Net Earnings %  3.1% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  3.1% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  4.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  13.3% 10.9% 62.9% 2.3% 1.7%  
ROI %  17.6% 19.2% 133.0% 4.0% 3.1%  
ROE %  67.4% 41.7% 103.0% 2.0% 2.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  12.8% 29.0% 59.3% 56.7% 52.2%  
Relative indebtedness %  31.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  30.1% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  451.6% -28.4% -16.8% 132.9% 170.7%  
Gearing %  490.4% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.5% 0.6% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.1 1.4 2.5 2.3 2.1  
Current Ratio  1.1 1.4 2.5 2.3 2.1  
Cash and cash equivalent  31.6 30.2 101.7 81.4 40.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  5.5 0.0 0.0 0.0 0.0  
Current assets / Net sales %  35.6% 0.0% 0.0% 0.0% 0.0%  
Net working capital  153.3 234.2 731.0 745.8 763.8  
Net working capital %  4.5% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  3,374 0 0 0 0  
Added value / employee  160 106 605 -61 -12  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  160 106 605 -61 -12  
EBIT / employee  160 106 605 -61 -12  
Net earnings / employee  103 81 497 15 9